共 50 条
- [3] FDA Approves Two New Indications and Dosage Form for Pembrolizumab ONCOLOGY-NEW YORK, 2019, 33 (05): : 186 - 186
- [6] FDA Approves First Sublingual Therapies for Allergic Rhinitis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (20): : 2057 - 2057
- [10] FDA approves broad hepatitis C treatment LANCET INFECTIOUS DISEASES, 2016, 16 (10): : 1118 - 1119